GQG Partners LLC purchased a new position in The Allstate Corporation (NYSE:ALL - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 5,235,375 shares of the insurance provider's stock, valued at approximately $1,245,710,000. Allstate accounts for 2.3% of GQG Partners LLC's investment portfolio, making the stock its 13th largest position. GQG Partners LLC owned approximately 2.07% of Allstate as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also bought and sold shares of the company. Brighton Jones LLC grew its stake in Allstate by 60.2% during the fourth quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider's stock worth $1,253,000 after buying an additional 2,443 shares in the last quarter. Revolve Wealth Partners LLC bought a new position in Allstate in the 4th quarter valued at about $231,000. WINTON GROUP Ltd acquired a new position in shares of Allstate in the 2nd quarter valued at approximately $210,000. Treasurer of the State of North Carolina raised its position in shares of Allstate by 2.5% in the 2nd quarter. Treasurer of the State of North Carolina now owns 123,272 shares of the insurance provider's stock valued at $24,816,000 after buying an additional 3,051 shares in the last quarter. Finally, Ieq Capital LLC lifted its holdings in shares of Allstate by 20.1% during the 2nd quarter. Ieq Capital LLC now owns 38,316 shares of the insurance provider's stock worth $7,713,000 after acquiring an additional 6,412 shares during the period. Institutional investors and hedge funds own 76.47% of the company's stock.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on ALL. Raymond James Financial reiterated a "strong-buy" rating and issued a $315.00 price target on shares of Allstate in a research note on Tuesday, August 11th. Keefe, Bruyette & Woods restated an "underperform" rating and issued a $250.00 target price (down from $255.00) on shares of Allstate in a research report on Thursday. JPMorgan Chase & Co. boosted their target price on shares of Allstate from $282.00 to $292.00 and gave the stock an "overweight" rating in a research note on Tuesday, August 11th. Cantor Fitzgerald raised their price objective on Allstate from $236.00 to $242.00 and gave the company a "neutral" rating in a report on Thursday, July 9th. Finally, Weiss Ratings raised Allstate from a "buy (a-)" rating to a "buy (a)" rating in a report on Thursday, August 6th. Four research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, eight have issued a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $265.26.
View Our Latest Report on ALL
Insider Buying and Selling at Allstate
In other news, insider John E. Dugenske sold 32,996 shares of Allstate stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $269.33, for a total value of $8,886,812.68. Following the completion of the transaction, the insider directly owned 13,054 shares of the company's stock, valued at approximately $3,515,833.82. This trade represents a 71.65% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Andrea Redmond sold 2,225 shares of the business's stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $202.91, for a total value of $451,474.75. Following the completion of the transaction, the director directly owned 2,225 shares in the company, valued at $451,474.75. This represents a 50.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 91,446 shares of company stock valued at $24,208,675. 1.55% of the stock is currently owned by insiders.
Allstate Trading Down 0.3%
Shares of ALL stock opened at $253.82 on Friday. The Allstate Corporation has a 1-year low of $188.08 and a 1-year high of $277.22. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.24. The stock has a market cap of $64.18 billion, a price-to-earnings ratio of 5.07, a PEG ratio of 0.39 and a beta of 0.16. The stock has a 50-day moving average of $250.34 and a 200-day moving average of $224.95.
Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The insurance provider reported $8.99 EPS for the quarter, topping analysts' consensus estimates of $6.06 by $2.93. The company had revenue of $18.60 billion for the quarter, compared to analyst estimates of $15.46 billion. Allstate had a return on equity of 41.64% and a net margin of 18.97%.The firm's quarterly revenue was up 11.8% on a year-over-year basis. During the same period in the previous year, the firm earned $5.94 earnings per share. On average, equities research analysts forecast that The Allstate Corporation will post 34.45 earnings per share for the current year.
Allstate Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Monday, August 31st will be issued a $1.08 dividend. The ex-dividend date is Monday, August 31st. This represents a $4.32 annualized dividend and a yield of 1.7%. Allstate's payout ratio is presently 8.63%.
Key Stories Impacting Allstate
Here are the key news stories impacting Allstate this week:
- Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
- Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
- Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
- Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
- Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
- Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates
About Allstate
(
Free Report)
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
See Also
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report